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ABSTRACT

ASP
review
characteristics,
antibiotic(s) prescribed, clinical

Introduction: Antibiotic stewardship programs
(ASP) improve appropriate antibiotic use. Data

recommendations made by the ASP, and
agreement with recommendations. Propensity

are limited on the clinical benefit of ASPs in

score analysis was utilized to determine the

children’s hospitals. This study’s objective was
to determine the impact of an ASP on length of

impact of the ASP on LOS and 30-day
readmission based on whether the patient

stay (LOS) and readmission rate among patients
admitted to children’s hospitals.

received an ASP recommendation and if the
clinician agreed with recommendations.

Methods: Data

prospective-audit-

Patients were stratified on if they had a

with-feedback ASP were used to examine the

complex chronic condition status (CCC) and
their service line, medical or surgical.

Enhanced content To view enhanced content for this
article go to.http://www.medengine.com/Redeem/
9527F060087BCCAA.

Results: Of the 8038 reviews included, 1362
(16.9%) resulted in a recommendation that was

from

a

Electronic supplementary material The online
version of this article (doi:10.1007/s40121-016-0139-5)
contains supplementary material, which is available to
authorized users.
B. R. Lee (&)  J. L. Goldman  D. Yu 
A. L. Myers  E. Hedican  M. A. Jackson
Division of Pediatric Infectious Diseases, Children’s
Mercy Hospital and Clinics, Kansas City, MO, USA
e-mail: blee@cmh.edu
B. R. Lee
Health Services and Outcomes Research, Children’s
Mercy Hospital and Clinics, Kansas City, MO, USA
J. L. Goldman
Divisions of Clinical Pharmacology, Toxicology and
Therapeutic Innovation, Children’s Mercy Hospital
and Clinics, Kansas City, MO, USA

including
indication,

agreed with in 1116 (81%) cases. Propensity
score analysis demonstrated a significantly
longer LOS for the non-CCC medicine group
L. M. Stach
Department of Pharmacy, Ann & Robert H. Lurie
Children’s Hospital of Chicago, Chicago, IL, USA
J. G. Newland
Division of Pediatric Infectious Diseases,
Washington University in St. Louis School of
Medicine, St. Louis, MO, USA

Infect Dis Ther (2017) 6:103–113

104

who received an ASP recommendation (80.9 vs.

[2, 3]. Furthermore, these programs have been

67.6 h, p\0.001). However, for CCC medicine
patients
that
agreed
with
the
ASP

associated with an up to US$200,000 reduction

recommendation, a clinically relevant decrease
in LOS (158.1 vs. 180.3 h, p = 0.095) was
observed. The 30-day readmission rate was
significantly greater in CCC medicine patients
when comparing those who did not receive a
recommendation versus those who did receive a
recommendation (7.3% vs 4.2%, respectively;
p = 0.005).
Conclusion: Children without a CCC who
received an ASP recommendation had a longer
length of stay. For children with CCCs, the ASP
appeared to decrease LOS and significantly
reduce 30-day readmission rates. Overall, this
study demonstrate that ASPs offer meaningful
clinical benefit justifying resource allocation

in antibiotic acquisition costs [4]. Finally,
pediatric clinicians impacted by ASPs believe
these programs improve the overall care of
patients and provide knowledge about the
appropriate use of antibiotics [5].
Nevertheless, data are limited on whether a
pediatric ASP results in a clinical benefit for
hospitalized children. Among adult hospital
ASPs, studies have demonstrated a decrease in
the length of stay in the medical ICU, a
reduction in Clostridium difficile rates, and an
improvement in antibiotic susceptibilities of
common pathogens [6–8]. The objective of
this study was to determine the impact of a
children’s hospital ASP on hospital length of
stay (LOS) and rate of readmission.

needed to develop and maintain ASP programs.
Keywords: Antibiotic stewardship; Length of

METHODS

stay; Outcomes; Readmission

Study Design, Setting and Data Sources

INTRODUCTION

A single-center cohort study was performed at a

Antibiotic

resistant

bacteria

kill

23,000

Americans and infect another 2 million
annually [1]. Compounding this problem is

quaternary care freestanding 354-bed children’s
hospital.
On
March
3,
2008
a
prospective-audit-with-feedback

ASP

was

the lack of new antibiotics targeted against the

implemented,
focused
on
delineating
appropriateness of antibiotic use in children

most highly resistant
carbapenem-resistant

bacteria such as
Enterobacteriaceae

who had received a defined group of antibiotics
(Supplemental Table 1) for two calendar days

(CRE). Antibiotic stewardship programs have
been implemented in hospitals to improve the

[3, 5]. An infectious diseases (ID) pharmacist

use of antibiotics and limit the unnecessary
antibiotic pressure that contributes to antibiotic
resistance.
Antibiotic stewardship programs (ASP) have
been valuable in children’s hospitals. Many
pediatric ASPs have significantly reduced the
overall use of antibiotics without a reported
increase in patient harm or antibiotic resistance

and ID physician reviewed the clinical data and
provided
recommendations
that
were
categorized into four areas: (1) stop therapy,
(2) modify the antibiotic type, (3) modify the
antibiotic dosage and/or duration and (4)
obtain an ID consultation [9].
The ASP repository was utilized to capture
the data collected on each patient review
including: antibiotic(s) prescribed, antibiotic
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clinical

imaging, and laboratory) into PHIS. Data are

and

de-identified at the time of data submission and

recommendations made by the ASP. After
verbal feedback to the provider, agreement or

data are subjected to a number of reliability and
validity checks before being included in the

disagreement with recommendations was
confirmed and, for those who agreed,

database. Using internal patient identifiers, the
repository data was merged with the data

compliance

obtained from PHIS.

indication,
indication,

dose

of

length

and

antibiotic(s),
of

follow

therapy,

through

with

recommendations was documented. Since a
patient could be reviewed by the ASP more

Compliance with Ethics Guidelines

than once during an admission, each patient
encounter was referred to as a review. Patients’

This article does not contain any new studies

demographic data as well as the length of
hospitalization was obtained from the
electronic health record. Data from the ASP

with human or animal subjects performed by
any of the authors. This study was approved by
Children’s Mercy Hospital’s institutional review

repository was merged with the corresponding
hospital data in Pediatric Health Information

board.

System (PHIS) database in order to obtain

Study Population

additional data elements.
The PHIS database was utilized to identify
patients
with
complex
chronic
care
condition(s) (CCC) ICD9 discharge diagnosis

The study population included all individuals
with a single ASP review from March 3, 2008 to
March 2, 2014. Data were analyzed related to

codes [10] and to determine the prevalence of
30-day readmission for the same all-patient

the APR-DRG medical or surgical category, and
the presence of a CCC ICD9 code. Children

refined diagnosis-related groups (APR-DRG).

admitted to the pediatric intensive care unit,
neonatal intensive care unit, hematology/

PHIS is an administrative database that
contains inpatient, emergency department,
ambulatory surgery and observation data from
48 not-for-profit, tertiary care pediatric

oncology unit, those who died, and those with
more than one ASP review during their
hospitalization

hospitals in the United States. These hospitals

analysis.

are affiliated with the Children’s Hospital
Association (Mission, KS, USA). Data quality

Outcomes

and reliability are assured through a joint effort
between the Children’s Hospital Association
and

participating

hospitals.

The

data

warehouse function for the PHIS database is
managed by Truven Health Analytics (Ann
Arbor, MI, USA). For the purposes of external
benchmarking, participating hospitals provide
discharge/encounter

data

including

demographics, diagnoses, and procedures.
Nearly all of these hospitals also submit
resource utilization data (e.g., pharmaceuticals,

were

excluded

from

the

The primary outcomes were hospital LOS and
30-day hospital readmission rates. Length of
stay was calculated as the number of hours
between the patients’ admission and discharge
from the hospital. A patient was included in the
30-day readmission rate if PHIS assessed data
confirmed they were readmitted as an inpatient
to the hospital within 30 days of the prior
discharge with the same APR-DRG as the prior
hospitalization.
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Statistical Analysis

IPW estimates. We report the difference in
median LOS and difference in proportion

First,

unadjusted

differences

in

LOS

and

readmission based on two separate ‘‘treatment’’
indicators were calculated. The first indicator
was whether the ASP
recommendation related

provider gave a
to the patient’s

antibiotic

second

regimen.

The

readmitted. List-wise deletion was done for
instances where agreement status was not
documented.

RESULTS

indicator

focused on those receiving a recommendation,
related to agreement or disagreement with the

ASP providers performed 17,422 reviews during

recommendations. Both treatment indicators
were modeled as binary indicators.

(n = 1707), the NICU (n = 1893), or the
hematology/oncology service (n = 3460), who

Adjusted

differences

in

the

primary

the study period. Patients admitted to the PICU

had more than one review (n = 2038), who had
incomplete data for analysis (n = 261) or who

outcomes were then calculated using inverse
probability-weighted (IPW) estimates as a

died (n = 25) were excluded, resulting in 8038

means to control for possible confounding.
The propensity score was calculated using

total reviews for analysis. Among the total 8038
reviews, 1362
(16.9%) resulted in a

multiple factors that were hypothesized to be

recommendation which was agreed with in
1116 (81.9%) cases.

related to an ASP recommendation: (1) patient’s
age and sex, (2) year since the ASP program was

Table 1

shows

the

demographic/clinical

implemented, (3) clinical indication for
antibiotic treatment, (4) the prescribed

characteristics by the four CCC categories
that were included in this study. Patients

antibiotic(s), (5) patient’s CCC status, and 6)

classified as CCC surgical had the highest
percentage of recommendations (28.1%) while

the clinical service line. In an effort to increase
statistical efficiency, we utilized stabilized IPWs

non-CCC surgical had the lowest (8.9%).

[11–13]. We hypothesized that LOS and
readmission would be significantly related to

Disagreement with recommendations was
highest in patients who were classified as

the patient’s clinical service and the underlying

having a CCC (Fig. 1).
Suspected sepsis was the most frequently

chronic conditions. Consequently, we stratified
all analysis by four distinct categories: (1) CCC

identified indication for antibiotics among

Surgical, (2) Non-CCC Surgical, (3) Non-CCC
Medicine and (4) CCC Medicine.

non-CCC medicine children (n = 1060) and
ceftriaxone was the most common ASP

All analyses were completed with Stata

monitored-antibiotic prescribed in those
patients
(Supplemental
Fig. 1,
2).
An

software (v.13.1; StataCorp, College Station,
TX, USA). For the unadjusted analysis, the

ASP-monitored

drug

plus

concurrent

median LOS was calculated and the Wilcoxon
Rank-Sum test used to determine statistical

metronidazole was most commonly identified
among surgical patients. Patients with CCCs

significance,

most commonly received an ASP-monitored
drug
plus
concurrent
clindamycin;

while

the

prevalence

of

readmission was compared using Fisher’s exact
test. A p value \0.05 was used to determine
statistical significance. Quintile and logistic
regression models were used for calculating

additionally, this group of patients often had
two or more indications for antibiotics being
prescribed.

Overall,

those

with

Infect Dis Ther (2017) 6:103–113
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Table 1 Patient demographics and ASP review characteristics, by complex chronic conditions (CCC) status and
medicine/surgical service line
Non-CCC, surgery
(N 5 1172)
Male, n (col. %)

CCC, surgery
(N 5 524)

Non-CCC, medicine
(N 5 4092)

CCC, medicine
(N 5 2250)

692 (59.0%)

288 (55.0%)

2024 (49.5%)

1192 (53.0%)

0–5 months

20 (1.7%)

123 (23.5%)

1971 (48.2%)

287 (12.8%)

6–17 months

28 (2.4%)

74 (14.1%)

443 (10.8%)

240 (10.7%)

18–59 months

176 (15.0%)

101 (19.3%)

593 (14.5%)

387 (17.2%)

5–12 years

644 (54.9%)

119 (22.7%)

731 (17.9%)

550 (24.4%)

13? years

304 (25.9%)

107 (20.4%)

354 (8.7%)

786 (34.9%)

1

193 (16.5%)

96 (18.3%)

940 (23.0%)

418 (18.6%)

2

205 (17.5%)

102 (19.5%)

826 (20.2%)

403 (17.9%)

3

199 (17.0%)

93 (17.7%)

721 (17.6%)

360 (16.0%)

4

215 (18.3%)

91 (17.4%)

608 (14.9%)

388 (17.2%)

5

196 (16.7%)

82 (15.6%)

505 (12.3%)

328 (14.6%)

6

164 (14.0%)

60 (11.5%)

492 (12.0%)

353 (15.7%)

Medicaid

430 (36.7%)

226 (43.1%)

1983 (48.5%)

1074 (47.7%)

Commercial

614 (52.4%)

260 (49.6%)

1725 (42.2%)

938 (41.7%)

Self-pay

83 (7.1%)

10 (1.9%)

223 (5.4%)

75 (3.3%)

Other/unknown

45 (3.8%)

28 (5.3%)

161 (3.9%)

163 (7.2%)

104 (8.9%)

147 (28.1%)

638 (15.6%)

473 (21.0%)

32/134 (23.9%)

105/611 (17.2%)

92/448 (20.5%)

Age

ASP year

Primary insurance

Any recommendations
Disagreed with recommendations,
N/n (col. %)

17/98 (17.3%)

the

who received an ASP recommendation had a

highest percentage of recommendations
(35.8%; Supplemental Fig. 2).

significantly longer median LOS than children
who did not receive a recommendation (81.5 vs.

community-acquired

pneumonia

had

66.4 h, p\0.001). A significantly longer LOS
Outcomes

was also observed for the non-CCC surgery
group (difference of 5 h, p = 0.015). Differences

The unadjusted median LOS between children
receiving a recommendation versus no

in length
significant

recommendation was similar in 2 of the 4
groups (Table 2). Non-CCC medicine children

agreement with the ASP recommendations
(Table 3).

of stay were not statistically
when evaluating based upon
When

disagreement

with

ASP

Infect Dis Ther (2017) 6:103–113
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recommendations was documented in the

medicine

CCC-medicine

longer

recommendation (Table 2; 80.9 vs. 67.6 h,

hospitalization was observed (p = 0.101).
After performing the IPW analysis, the LOS

p\0.001). Differences in median LOS
remained non-significant for all four groups

remained significantly longer for the non-CCC

when comparing agreement status. The median
LOS was longer for CCC medicine patients

group,

a

28 h

when

group

there

was

who

received

disagreement

a

with

recommendations versus agreement; however,
this was not determined to be statistically
significant (180.3 vs. 158.1, p = 0.095).
Differences in the unadjusted 30-day
readmission rate were non-significant for all 4
groups (Tables 4, 5). After performing IPW
analysis, the readmission rate was significantly
greater in children on a medicine service with a
CCC that did not receive a recommendation
versus those who did receive a recommendation
Fig. 1 The percent of disagreement by patient group and
recommendation type

(7.3% vs 4.2%, p = 0.005). The readmission
rates for CCC surgery patients without a

Table 2 Comparison of length of stay (LOS) between patients with an ASP recommendation and patients without a
recommendation, by complex chronic conditions (CCC) status and medicine/surgical service line
N

Unadjusted
Median LOS

Inverse-probability weighted
95% CI

p value

Lower

Upper

Median LOS

95% CI

p value

Lower

Upper

115.60

104.77

126.43

115.27

111.78

118.77

214.63

175.79

253.47

214.56

185.88

243.24

Non-CCC, surgery
Recommendations

104

120.42

114.25

138.06

1068

115.20

112.72

118.80

Recommendations

147

214.89

186.74

265.09

No Recommendations

377

213.25

182.01

251.26

638

81.46

75.77

85.82 \0.001

80.86

78.43

83.30 \0.001

3454

66.41

65.06

67.68

67.61

66.24

68.99

473

156.78

140.57

168.28

184.27

168.63

199.90 \0.001

1777

162.67

145.24

169.67

150.48

139.97

160.99

No Recommendations

0.015

0.955

CCC, surgery
0.286

0.998

Non-CCC, medicine
Recommendations
No Recommendations
CCC, medicine
Recommendations
No Recommendations

0.575

Infect Dis Ther (2017) 6:103–113
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Table 3 Comparison of length of stay (LOS) between clinician
disagreement with ASP recommendation and agreement with a
recommendation, by complex chronic conditions (CCC) status and

N

medicine/surgical service line (agreement status was not recorded for
all patients)

Unadjusted

Inverse-probability weighted

Median
LOS

95% CI

p value

Lower

Upper

Median
LOS

95% CI

p value

Lower

Upper

136.68

111.32

162.04

118.11

98.35

137.87

214.63

141.29

287.97

211.35

160.69

262.02

84.58

75.38

93.77

80.90

76.09

85.71

180.33

159.66

201.01

158.05

142.09

174.01

Non-CCC,
surgery
Disagreed

17

136.10

119.89

208.26

Agreed

81

118.11

111.59

141.78

32

236.31

153.46

420.41

102

208.39

183.03

265.93

Disagreed

105

84.25

72.09

92.55

Agreed

506

80.81

74.67

86.07

92

174.89

143.56

241.06

356

146.33

138.32

168.06

0.214

0.258

CCC, surgery
Disagreed
Agreed

0.569

0.943

Non-CCC,
medicine
0.603

0.487

CCC, medicine
Disagreed
Agreed

0.101

0.095

recommendation was 1.7% higher than those

recommendation.

who received a recommendation, though that
difference was not statistically significant

common for all patients that did not generate
an ASP recommendation.

(p = 0.078).

No

statistically

significant

As

hospitals

Readmissions

continue

to

were

develop

more

and

differences in readmission rates were observed
based upon agreement status in either the

implement ASPs, studies evaluating both
positive clinical benefits and possible negative

unadjusted or IPW analyses.

outcomes are necessary. In this study, we
hypothesized a significant positive clinical

DISCUSSION

benefit would be observed through a decrease

We present the largest study to date evaluating
the impact of an ASP on length of stay and
readmission rates in patients hospitalized at a
children’s hospital. Length of stay was observed

in LOS and decrease in 30-day readmission rate.
In a previous study, we demonstrated that
among patients admitted to a hospitalist
service LOS was longer for patients having an
ASP recommendation that was agreed upon by

to be longer for non-CCC children admitted to
a medical service who received an ASP

the hospitalist service [14]. In this study, which
evaluated patients admitted to hospitalist and

recommendation, regardless of acceptance. In

general pediatric services, the LOS was increased
for non-CCC medicine patients receiving an

contrast, a shorter LOS (22 h) was identified in
children with CCCs hospitalized on a medicine
service when providers agreed with the ASP

ASP recommendation but was not increased
when comparing whether the provider agreed

Infect Dis Ther (2017) 6:103–113
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Table 4 Comparison of 30-day readmission between patients with an ASP recommendation and patients without a
recommendation, by complex chronic conditions (CCC) status and medicine/surgical service line
N

Unadjusted
Readmitted
(%)

Inverse-probability weighted
95% CI

p value Readmitted
(%)
Lower Upper

95% CI

p value

Lower Upper

Non-CCC, surgery
Recommendations

104 0.00%

–

–

No
Recommendations

0.615

1068 1.12%

0.64%

1.97%

Recommendations

147 0.68%

0.09%

4.72%

No
Recommendations

377 2.39%

1.24%

4.53%

Recommendations

638 2.82%

1.78%

4.44%

No
Recommendations

3454 2.26%

1.81%

2.81%

Recommendations

473 4.86%

3.25%

7.22%

No
Recommendations

1777 7.37%

6.24%

8.68%

CCC, surgery
0.296

0.56%

0.07%

4.32%

2.26%

1.17%

4.34%

2.44%

1.47%

4.03%

2.30%

1.85%

2.85%

4.21%

2.76%

6.36%

7.29%

6.17%

8.59%

0.078

Non-CCC, medicine
0.393

0.834

CCC, medicine
0.064

0.005

or disagreed with the ASP recommendation.

diagnoses such as tracheitis [3, 9]. Similar

The increase in LOS seen among patients
receiving a recommendation by the ASP and

disagreements in the CCC patients identified
in this study may have led to longer durations

not based upon agreement status could be the

of these broad-spectrum antimicrobial therapies

result
of
the
patients
requiring
a
recommendation having a more serious illness

and longer lengths of stay.
In addition to a reduction in LOS, children

that we were unable to account for in our
analysis.

with CCCs in whom an ASP recommendation
was made experienced a 3% decrease in 30-day

Children with a CCC on a medicine service

readmission rates. Preventable readmissions

had almost a 1-day decrease in LOS when a
provider agreed with the ASP. Previously, we

among children with CCCs provide an excess
burden to families and patients and are

identified stopping antibiotics as the most
common
ASP
recommendation
and

associated with significant avoidable hospital
costs. In previous years, children’s hospitals

demonstrated that disagreements with ASP

have seen an increase in admissions among

recommendations most often occurred related
to narrowing use of broad-spectrum antibiotics

children with CCCs [15]. Data have shown that
children with CCCs are often readmitted and

(e.g.,

the greater number of CCCs a child has

linezolid,

carbapenems)

and

among

Infect Dis Ther (2017) 6:103–113
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Table 5 Comparison of 30-day readmission between clinician
disagreement with ASP recommendation and agreement with a
recommendation, by complex chronic conditions (CCC) status and

N

medicine/surgical service line (agreement status was not recorded for
all patients)

Unadjusted

Inverse-probability weighted

Readmitted
(%)

95% CI

p value

Lower

Upper

Readmitted
(%)

95% CI

p value

Lower

Upper

0.00%

–

–

–

0.00%

–

–

–

1.000

0.00%

–

–

–

1.000

3.86%

1.42%

10.02%

0.655

2.93%

1.77%

4.82%

4.87%

1.99%

11.42%

4.78%

2.99%

7.56%

Non-CCC,
surgery
Disagreed

17

0.00%

–

–

Agreed

81

0.00%

–

–

32

0.00%

–

–

102

0.98%

0.13%

6.80%

Disagreed

105

2.86%

0.92%

8.55%

Agreed

506

2.96%

1.79%

4.87%

92

5.43%

2.26%

12.48%

356

4.49%

2.77%

7.22%

–

CCC, surgery
Disagreed
Agreed
Non-CCC,
medicine

CCC, medicine
Disagreed
Agreed

0.781

0.972

increases the risk [16]. Many factors impact the

find similar to greater success in the reduction

care of these complex children, but our data
suggest that input from ASP providers can

of LOS and readmission rates. Finally, while we
tried to account for severity of illness within our

positively impact the care for these children

comparison

and may result in significant cost savings. The
findings from this study also support that

analyses, we recognize
unmeasured confounders

enforcing the judicious use of antimicrobials
did not have undesired implications such as an

impacted our propensity score calculations
and potentially affected the exchangeability of

increase in readmission rates.

treatment groups.

This study has several limitations. First, we
did not include all patients reviewed by our
ASP. This could result in underestimating the
impact of the ASP as data have shown that

groups

by

performing
that
that

IPW

there are
may have

CONCLUSION

intensive care unit lengths of stay have been

This study demonstrates the clinical impact that
is realized when a formal ASP is implemented in

significantly reduced by the presence of ASPs
[6]. Second, this study was done at one

a children’s hospital. For hospitalized children
with CCCs whose care resulted in an ASP

institution with an ASP that focuses on the use
of prospective-audit with feedback. Other ASPs

intervention, shorter hospital stays and less

utilizing different strategies potentially could

readmissions were confirmed. As health care
models for reimbursement continue to change

Infect Dis Ther (2017) 6:103–113
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toward a bundled payment model, the presence

Data Availability. The datasets during and/

of a formal ASP in a hospital is essential to

or analyzed during the current study are
available from the corresponding author on

ensure optimal care for patients, and especially
for those with special healthcare needs. Future
research is needed to understand the impact on
specific patient populations (e.g., PICU, NICU,

reasonable request.

hematology-oncology) for which ASPs might
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